Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

STEP 3

Novo Nordisk · Phase 3 · Completed · Enrollment 611

NCT03611582

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutiden/rn/rn/rn/rn/r
Semaglutide placebon/rn/rn/rn/rn/r
Semaglutide 2.4 mg, in trial237 participants111 participants147 participantsn/r0
Placebo, in trial45 participants22 participants45 participantsn/r0

A count stays a count. This page does not turn a count into a percent.